Schedule 13G ownership disclosure

Zevra Therapeutics Inc

Security class unavailable · CUSIP: 488445206

Event date: 2021-01-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,000,000
Percent of class
8.5800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-002768
Form type
SC 13G
Filer
Auctus Fund, LLC
CIK
CIK 1802012
Filed
Feb 05, 2021
Reporting period
Jan 26, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub